In compliance with current regulations, let us know which audience you belong to:
Espansione Group is proud to announce MeiboMetrics, a groundbreaking AI-powered algorithm for the segmentation and quantitative measurement of meibomian glands.
This innovative solution has been developed in partnership with the Institute of Biomedical and Neural Engineering at Reykjavik University, leveraging a joint effort initiated in early 2023. Espansione Group and Reykjavik University have combined their expertise in eye care and imaging technology, alongside novel capabilities in machine learning and artificial intelligence, to develop a state-of-the-art tool that promises to revolutionize the screening process for meibomian gland dysfunction.
Vis-à-vis traditional Meibographies, MeiboMetrics introduces several unprecedented advancements to the field of Meibomian Glands analysis by leveraging advanced calculations.
This enables the novel algorithm to:
Dr. Paolo Gargiulo, Full Professor, Founder and Director at Reykjavick University’s Institute for Biomedical and Neural Engineering, noted that “The software is based on a novel approach that uses sophisticate bio-imaging techniques to measure and assess meibomian glands. This new solution provides a quantitative evaluation of dry eye condition advancing the state-of-the-art technology in the field.”
MeiboMetrics represents a significant innovation in the quantitative measurement of meibomian gland dysfunction, paving the way for data-driven patient management and more personalized care.
As a testament to Espansione Group's commitment to advancing ophthalmology, the algorithm will be available on the me-check® Pro and other platforms starting from 2025, promising to set a new benchmark in the field.
About Reykjavik University
The role of Reykjavik University (RU) is to create and disseminate knowledge in order to enhance the competitiveness and quality of life for individuals and society, guided by good ethics,
sustainability, and responsibility.
The Institute of Biomedical and Neural Engineering (Heilbrigdistaeknisetur) is an internationally recognized research center established by the University Hospital Landspitali and Reykjavik University with the aim to improve healthcare processes and translational research in biomedicine.
Visit the university's website at en.ru.is
About Espansione Group
Espansione Group is a pioneer in the medtech industry, on a mission to develop and market innovative, non-invasive solutions for prevention and management of conditions in ophthalmology and beyond.
The company’s certified medical solutions leverage proprietary technologies such as Light Modulation™ Low-level Light Therapy (LM™ LLLT) photobiomodulation (PBM), with an ambition to redefine standards of care by expanding on their applications, with a constant commitment to science, research and development, and customer excellence.
Strategic partnerships with the industry, a strong commitment to scientific excellence and a will to shape the future have enabled Espansione Group’s advanced medical technologies to be present in over 50 countries, serving thousands healthcare providers worldwide.
For more information, see www.espansionegroup.it
Espansione Group Press Office
press@espansione.it
© 2024 Espansione Group, All Rights Reserved
Posted on September 17th, 2024 in Newsroom